Helen Torley, PRESIDENT AND CEO at HALOZYME THERAPEUTICS, INC. (HALO), sold 86,519 shares at $69.20 ($6.0M) on 2026-03-02, disclosed to the SEC on 2026-03-04.
Open-market sale of $6.0M HALO by PRESIDENT AND CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.20 | 4,100 | $284K | 4.7% |
| 2 | $69.20 | 4,100 | $284K | 4.7% |
| 3 | $69.80 | 15,322 | $1.1M | 17.8% |
| 4 | $69.80 | 15,322 | $1.1M | 17.8% |
| 5 | $70.46 | 578 | $41K | 0.7% |
| 6 | $70.46 | 578 |
| $41K |
| 0.7% |
| 7 | $68.85 | 13,481 | $928K | 15.4% |
| 8 | $69.33 | 6,519 | $452K | 7.5% |
| 9 | $69.33 | 6,519 | $452K | 7.5% |
| 10 | $69.94 | 7,329 | $513K | 8.5% |
| 11 | $69.94 | 7,329 | $513K | 8.5% |
| 12 | $70.94 | 2,671 | $189K | 3.1% |
| 13 | $70.95 | 2,671 | $190K | 3.1% |
| Total | $69.63 avg | 86,519 | $6.0M | 100% |
| Filing → |
| HALO | SELL | 2026-07-09 | $153K | — | Filing → |
| HALO | SELL | 2026-06-03 | $3.4M | — | Filing → |
| HALO | SELL | 2026-05-13 | $3.4M | — | Filing → |